Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment

D'Aniello, C.; Cavaliere, C.; Fiorica, F.; Facchini, G.
November 2016
European Review for Medical & Pharmacological Sciences;Nov2016, Vol. 20 Issue 22, p4626
Academic Journal
Letter to the Editor
A letter to the editor is presented in response to the article "Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment" in the previous issue of the journal.


Related Articles

  • Cancer de prostată.  // Romanian Journal of Urology;2014, Vol. 13 Issue 2, p31 

    The article presents abstracts on medical topics which include the ecoguided prostate biopsy, use of multiparametric magnetic resonance imaging prostate cancer preoperative evaluation and the application of high-intensity focused ultrasound in localized prostate cancer treatment.

  • MRI guidance increases brachytherapy dosing accuracy. Guttman, Cheryl // Urology Times;Jun2000, Vol. 28 Issue 6, p14 

    Discusses the report from Harvard University in Boston and presented at the American Urological Association's (AUA) annual meeting, about the use of real-time magnetic resonance imaging (MRI) in I-125 brachytherapy to improve dose localization relative to ultrasonic-guided seed placement and...

  • Intl scientific cooperation to advance image-guided prostate cancer care.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article offers information related to a new joint effort has been taken by three research organizations including American College of Radiology, AdMeTech Foundation, and ESUR which aims at advancing image guided prostate cancer treatments for patients.

  • Imaging treated prostate cancer. De Visschere, P. J. L.; Vargas, H. A.; Ost, P.; De Meerleer, G. O.; Villeirs, G. M. // Abdominal Imaging;Dec2013, Vol. 38 Issue 6, p1431 

    In patients with a clinical suspicion of recurrence after treatment for prostate cancer, imaging can be used to distinguish between local recurrence and metastatic disease. Multiparametric magnetic resonance imaging (mpMRI) of the prostate may be a valuable imaging modality for the detection and...

  • Changes in Diffusion-Weighted Images for Visualizing Prostate Cancer during Antiandrogen Therapy: Preliminary Results. Nemoto, Kaoru; Tateishi, Toshiki; Ishidate, Takuzo // Urologia Internationalis;Dec2010, Vol. 85 Issue 4, p421 

    Objectives: To assess the potential of diffusion-weighted imaging (DWI) for monitoring the response to antiandrogen therapy in prostate cancer. Methods: After patients had undergone 6 months of antiandrogen therapy, we investigated the time-course changes in findings obtained from DWI compared...

  • Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer. Harisinghani, Mukesh G.; Barentsz, Jelle; Hahn, Peter F.; Deserno, Willem M.; Tabatabaei, Shahin; van de Kaa, Christine Hulsbergen; de la Rosette, Jean; Weissleder, Ralph // New England Journal of Medicine;6/19/2003, Vol. 348 Issue 25, p2491 

    Background: Accurate detection of lymph-node metastases in prostate cancer is an essential component of the approach to treatment. We investigated whether highly lymphotropic superparamagnetic nanoparticles, which gain access to lymph nodes by means of interstitial–lymphatic fluid...

  • Bildgeführte Strahlentherapie. Boda-Heggemann, J.; Guckenberger, M.; Ganswindt, U.; Belka, C.; Wertz, H.; Blessing, M.; Wenz, F.; Fuss, M.; Lohr, F. // Der Radiologe;Mar2012, Vol. 52 Issue 3, p213 

    Radiotherapy technology has improved rapidly over the past two decades. New imaging modalities, such as positron emission (computed) tomography (PET, PET-CT) and high-resolution morphological and functional magnetic resonance imaging (MRI) have been introduced into the treatment planning...

  • Multiparametrische MRT der Prostata zum Therapiemonitoring nach Strahlentherapie. Weidner, A.M.; Dinter, D.J.; Bohrer, M.; Sertdemir, M.; Hausmann, D.; Wenz, F.; Schoenberg, S.O. // Der Radiologe;Mar2012, Vol. 52 Issue 3, p235 

    Clinical/methodical issue: Radiation therapy is a therapeutic option with curative intent for patients with prostate cancer. Monitoring of prostate-specific antigen (PSA) values is the current standard of care in the follow-up. Imaging is recommended only for symptomatic patients and/or for...

  • Incremental value of T2-weighted and diffusion-weighted MRI for prediction of biochemical recurrence after radical prostatectomy in clinically localized prostate cancer. Nishida, Kaori; Yuen, Sachiko; Kamoi, Kazumi; Yamada, Kei; Akazawa, Kentaro; Ito, Hirotoshi; Okihara, Koji; Kawauchi, Akihiro; Miki, Tsuneharu; Nishimura, Tsunehiko // Acta Radiologica;Feb2011, Vol. 52 Issue 1, p120 

    Background: For men with clinically localized prostate cancer and candidates to receive radical prostatectomy (RP) a main concern is a cancer recurrence after treatment. Although previous studies have demonstrated the diagnostic utility of diffusion-weighted imaging (DWI) for prostate cancer,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics